AI assistant
Sending…
IDEAYA Biosciences, Inc. — Director's Dealing 2019
Jul 31, 2019
31547_dirs_2019-07-30_8b75f582-a5ff-4f80-bd5a-6a2e3d38a57d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEAYA Biosciences, Inc. (IDYA)
CIK: 0001676725
Period of Report: 2019-07-26
Reporting Person: Hager Jeffrey (SVP, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-26 | Common Stock | M | 5197 | $4.31 | Acquired | 127853 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-26 | Stock Option (right to buy) | $4.31 | M | 5197 | Disposed | 2028-04-12 | Common Stock (5197) | Direct |
Footnotes
F1: 25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
More from IDEAYA Biosciences, Inc.
Capital/Financing Update
2026
Jun 8
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 5
Earnings Release
2026
May 5
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Earnings Release
2026
Feb 17